| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |